Scully Scott Murphy & Presser
Compound inhibiting activities of BTK and/or JAK3 kinases
The present invention relates to a compound inhibiting the activities of Bruton's tyrosine kinase (BTK) and/or Janus kinase 3 (JAK3), a pharmaceutical composition of the compound, pharmaceutical applications of same, a method for using the compound in inhibiting the activities of BTK and/or JAK3, and a method for using the compound in treatment and/or prevention of BTK- and/or JAK3-mediated diseases or disorders in mammals (especially human). The compound is as represented by structural formula (I).
BEIJING HANMI PHARMACEUTICAL CO., LTD.
A A A A A C A A A A C A A C A A A A A A A A C
A61P A61P A61P A61K A61P C07D A61P A61P A61P A61P C07D A61P A61P C07D A61P A61P A61K A61K A61K A61P A61P A61P C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Gong Mi Young Hongjuan Zhanmei Maengsup Jinming
Li Cha Qiu Li Kim Liu